Dr.V. Sathya Suresh Attili Medical Oncologist in Hyderabad

Dr.V. Sathya Suresh Attili

Medical Oncologist, Hyderabad


  • 15 Years Experience
  • 1 Hospital


  • Languages : Hindi, English, Telugu, Kannada


Onconet Cancer Hospital, Haematologist and Medical Oncologist, Hyderabad - Currently working here


  • Medical Oncology

  • Hematology


MBBS, 1999, Institute of Medical Sciences, Banaras, India

MD (Medicine), 2003, Institute of Medical Sciences, Banaras, India

DM (Medical Oncology), 2007, Kidwai Memorial Institute of Oncology, Bangalore, India

Practice Information

Onconet Cancer Hospital, Hyderabad

Onconet Cancer Hospital, Hyderabad

Century Super Speciality Hospital, Road Number 12, Bhola Nagar, Banjara Hills, Hyderabad, Telangana - 500034


09:00 AM - 04:30 PM

Achievements & Contributions

  • Guest of Honor at “Emerging Trends in Biomarker Research – Prospects and Challenges” September13 & 14 , 2013 at IICT, Hyderabad
  • Submitted a thesis on “Associated Conditions in HIV/AIDS Patients” in 2003.
  • Communicated the work done in the PSM department titled “Awareness of the Rural Population Regarding Hepatitis B” during the rotatory internship
  • “Correlation of Hormone Receptors with HER-2”- The early results of the work were accepted for poster presentation at the ‘St Gallen Conference on Primary therapy of breast cancer 2009
  • ISO &ISMPO 2010, India
  • ISO &ISMPO 2012, India
  • IM- AMGEN molecule 2013, Malaysia
  • Selected for the Best/award papers at Indian Society of Oncology meet in 2006
  • Winner of the “Department of Science and technology-Govt of India” award for travel support to attend the International Symposium on the Hormone Carcinogenesis conducted in France, September 2006
  • Winner of the “Young Oncologist Supportive Award for Developing Nations” by the ESMO IASLC
  • Winner of the ‘Scholar in Training Award’ by American Association of Cancer Research (AACR) 2007.
  • Palliative chemotherapy in head and neck squamous cell cancer – What is best in Indian population? A time without symptoms, treatment toxicity score based study. Indian J Med Paediatric Oncology 2013;34:11.
  • Critical Review of ALK Pathway in Solid Tumors – Present and Future. The Journal of Pediatric Oncology, 2013, Vol. 1, No. 1 p3-8.
  • Hospital based observational study on the tolerability, and efficacy of two gemcitabine oxaliplatin regimens. Ann Oncol., 2013,24 (suppl 4):
  • Stem-cell therapy in medicine–how far we came and what we can expect? Apollo Medicine, March 2012, Volume 9, Issue 1 , Pages 41-43.
  • Agent Based Diagnostic Model for Cancer in Selected Organs using JADE. Procedia Technology 4, 2012, pages 303 – 310.
  • An Open Labeled Two Arm Study to Evaluate the Feasibility, Quality of Life, Safety and Efficacy of Darbepoetin as Compared to Erythropoietin In patients with Chemotherapy Induced Anemia in Patients with Gastrointestinal malignancies. Austral – Asian Journal of Cancer, 2012, Vol 11, No. 4.
  • Factors Influencing Progression-Free Survival in Gastrointestinal Stromal Tumors with Special Reference to Pathologic Features, Cytogenetics, and Radiologic Response. Gastrointestinal Cancer Res., Sep-Dec2011; 4(5-6): 173–177.
  • Interpretation of PET scan results at varying degrees of blood glucose in diabetic patients with lymphoma: an experience of 25 cases of Non Hodgkin Lymphomas from southern India. International Journal Of Diabetes In Developing Countries, 2011, Volume 31, Number 2,118-12.
  • Risk-scoring system for predicting mucositis in head and neck cancer receiving concurrent chemoradiotherapy [rssm-hn]. The Journal of Cancer Research&Therapy, 2010;6:448-51.
  • Anastomotic Leak as a Surrogate Marker for Shorter Disease Free Survival in Gastrointestinal Malignancies. Austral – Asian Journal of Cancer, January 2010, Vol. 9, No. 1, P 53-56.
  • Principles of Basic Sciences in Oncology- 2012
  • Gastrointestinal Complications in HIV- Fundamentals of HIV medicine- AAHIV 2010
  • Hepatic Complications in HIV- Fundamentals of HIV medicine- AAHIV 2010
  • Malignancies in HIV- – Fundamentals of HIV medicine- AAHIV 2010
  • Borderline Ovarian Tumors- Ovarian Cancers, contemporary and comprehensive management- Mc. Graw Hill Publication, 2009
  • Biological Therapies in Breast Cancer – TBC2007
  • DSMB Member for ISSAR clinical research appointed by the DCGI, Govt of India
  • Steering Committee Member – Amgen molecules on colorectal cancers, 2008-2015.
  • National Advisory Board Member -Jawaharlal Nehru Institute of Advanced Studies
  • Associate member- American Society of Clinical Oncology
  • Associate member – American Association of Cancer Research (AACR)
  • Member –European Society of Medical Oncology
  • Member – Indian Society of Medical and Pediatric Oncology

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr.V. Sathya Suresh Attili and his staff know how they are doing and how they can improve their services.